Dr. Samir C. Patel, M.D., Co-founded Ophthotech Corporation in January 2007 and served as its President since January 2007 until January 13, 2017. Dr. Patel served as the Chief Executive Officer of Ophthotech Corporation since January 2007 until April 2013. Dr. Patel Co-founded Eyegate Pharmaceuticals, Inc. and served as its Clinical Consultant. Dr. Patel served as the Chief of Clinical and Commercial Strategy and Chief Medical Officer of EyeTech Pharmaceuticals Inc. since January 2005. Previously, Dr. Patel served as a Consultant to EyeTech Pharmaceuticals Inc. from October 2001 to December 2004. Dr. Patel Co-founded Eyetech Pharmaceuticals, Inc. Dr. Patel served as the Residency Program Director at the University of Chicago from 1992 to July 2000. He serves as the Vice Chairman at Ophthotech Corporation. He served as a Director of Ophthotech Corporation since January 2007 until January 13, 2017. Dr. Patel served as an Independent Director of Eyetech Pharmaceuticals Inc. since February 2000. He served as a Director of Eyegate Pharmaceuticals, Inc. He served as a Director of Mimetogen Pharmaceuticals Inc. since March 1, 2007. From 1992 to June 2003, Dr. Patel served as a Director of the Retina Service at the University of Chicago and also served as its Associate Professor. Dr. Patel was the first surgeon to perform a retinal transplant in humans in the United States. Dr. Patel holds an M.D. from the University of Massachusetts Medical School and was an Ophthalmology Resident at the University of Chicago. Dr. Patel completed his fellowship training in retinal surgery at the Massachusetts Eye and Ear Infirmary, a teaching affiliate of Harvard Medical School. Dr. Samir C. Patel, M.D., Co-founded Ophthotech Corporation in January 2007 and served as its President since January 2007 until January 13, 2017. Dr. Patel served as the Chief Executive Officer of Ophthotech Corporation since January 2007 until April 2013. Dr. Patel Co-founded Eyegate Pharmaceuticals, Inc. and served as its Clinical Consultant. Dr. Patel served as the Chief of Clinical and Commercial Strategy and Chief Medical Officer of EyeTech Pharmaceuticals Inc. since January 2005. Previously, Dr. Patel served as a Consultant to EyeTech Pharmaceuticals Inc. from October 2001 to December 2004. Dr. Patel Co-founded Eyetech Pharmaceuticals, Inc. Dr. Patel served as the Residency Program Director at the University of Chicago from 1992 to July 2000. He serves as the Vice Chairman at Ophthotech Corporation. He served as a Director of Ophthotech Corporation since January 2007 until January 13, 2017. Dr. Patel served as an Independent Director of Eyetech Pharmaceuticals Inc. since February 2000. He served as a Director of Eyegate Pharmaceuticals, Inc. He served as a Director of Mimetogen Pharmaceuticals Inc. since March 1, 2007. From 1992 to June 2003, Dr. Patel served as a Director of the Retina Service at the University of Chicago and also served as its Associate Professor. Dr. Patel was the first surgeon to perform a retinal transplant in humans in the United States. Dr. Patel holds an M.D. from the University of Massachusetts Medical School and was an Ophthalmology Resident at the University of Chicago. Dr. Patel completed his fellowship training in retinal surgery at the Massachusetts Eye and Ear Infirmary, a teaching affiliate of Harvard Medical School.

Eye Diseases and Disorders